Attention!

This page contains information about prescription medications. According to the Russian regulatory requirements, this information can be available only for medical or pharmaceutical stuff.

Do you confirm that you are a medical of pharmaceutical specialist?

Report an adverse reaction
Main pageOur products
Innonafactor®

Innonafactor®

INN: Nonacog alfa

Description

Recombinant activated coagulation factor IX, which is required for the treatment of haemophilia B.

Innonafactor was launched onto the Russian market in 2014.

GENERIUM is the only company in the world, which manufactures three recombinant coagulation factors (FVII, FVII and FIX) for the treatment of hemophilia A and B, including its inhibitor form.